Kelly CRISPR & Gene Editing Technology ETF (XDNA) Short Interest Ratio & Short Volume

Short interest is the volume of Kelly CRISPR & Gene Editing Technology ETF shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 7,100 shares of XDNA short. Learn More on Kelly CRISPR & Gene Editing Technology ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XDNA shares currently have a short interest ratio of 2.0. Learn More on Kelly CRISPR & Gene Editing Technology ETF's short interest ratio.

Kelly CRISPR & Gene Editing Technology ETF saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 7,100 shares, a drop of 61.6% from the previous total of 18,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Kelly CRISPR & Gene Editing Technology ETF: Global X Wind Energy ETF (119.10%), Global X PropTech ETF (300.20%), SPDR MSCI USA Climate Paris Aligned ETF (0.75%), iShares Breakthrough Environmental Solutions ETF (2.63%), ProShares Ultra Nasdaq Cybersecurity ETF (0.11%), First Trust Indxx Metaverse ETF (2.40%), VanEck Green Infrastructure ETF (73.50%), Xtrackers US Green Infrastructure Select Equity ETF (0.59%), Global X AgTech & Food Innovation ETF (1.38%), Pacer BlueStar Engineering the Future ETF (1.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling XDNA is an investing strategy that aims to generate trading profit from Kelly CRISPR & Gene Editing Technology ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kelly CRISPR & Gene Editing Technology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XDNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XDNA, twice per month. The most recent reporting period available is November, 15 2023.